DCM
DAFNA Capital Management’s IDEAYA Biosciences IDYA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Buy |
619,090
+29,760
| +5% | +$626K | 3.59% | 8 |
|
|
2025
Q1 | $9.65M | Buy |
589,330
+90,503
| +18% | +$1.48M | 2.74% | 11 |
|
|
2024
Q4 | $12.8M | Buy |
498,827
+27,417
| +6% | +$705K | 3.26% | 11 |
|
|
2024
Q3 | $14.9M | Buy |
471,410
+49,197
| +12% | +$1.56M | 3.53% | 7 |
|
|
2024
Q2 | $14.8M | Sell |
422,213
-24,128
| -5% | -$847K | 3.54% | 6 |
|
|
2024
Q1 | $19.6M | Sell |
446,341
-70,000
| -14% | -$3.07M | 4.46% | 4 |
|
|
2023
Q4 | $18.4M | Buy |
516,341
+16,521
| +3% | +$588K | 4.4% | 4 |
|
|
2023
Q3 | $13.5M | Buy |
499,820
+20,000
| +4% | +$540K | 4.19% | 4 |
|
|
2023
Q2 | $11.3M | Buy |
479,820
+11,462
| +2% | +$269K | 3.08% | 9 |
|
|
2023
Q1 | $6.43M | Hold |
468,358
| – | – | 1.93% | 16 |
|
|
2022
Q4 | $8.51M | Sell |
468,358
-70,203
| -13% | -$1.28M | 2.4% | 12 |
|
|
2022
Q3 | $8.04M | Sell |
538,561
-10,000
| -2% | -$149K | 2.16% | 14 |
|
|
2022
Q2 | $7.57M | Buy |
548,561
+58,500
| +12% | +$807K | 2.06% | 13 |
|
|
2022
Q1 | $5.48M | Buy |
490,061
+30,000
| +7% | +$336K | 1.43% | 20 |
|
|
2021
Q4 | $10.9M | Hold |
460,061
| – | – | 2.73% | 7 |
|
|
2021
Q3 | $11.7M | Buy |
460,061
+128,400
| +39% | +$3.27M | 3.11% | 6 |
|
|
2021
Q2 | $6.96M | Hold |
331,661
| – | – | 1.46% | 17 |
|
|
2021
Q1 | $7.79M | Hold |
331,661
| – | – | 1.85% | 10 |
|
|
2020
Q4 | $4.64M | Hold |
331,661
| – | – | 1.38% | 18 |
|
|
2020
Q3 | $4.17M | Buy |
+331,661
| New | +$4.17M | 1.35% | 19 |
|